Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FLUO Trial
2024-513163-57-00Phase 2Authorised
- Sponsor
- Centro di Riferimento Oncologico di Aviano
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of indocyanine green in breast cancer, sponsored by Centro di Riferimento Oncologico di Aviano. Primary endpoint: Frequency of patient with at least 3 fluorescent lymph nodes. Planned start Oct 2024; status: authorised.
02
Drugs
indocyanine green
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2024-513163-57-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-513163-57-00.